Zhize Wang

机构：First Affiliated Hospital Zhejiang University · ORCID：0000-0003-4985-0877

发表论文 29 篇 · 总被引 412 次 · h-index 11

代表论文

• The Immune Checkpoint Regulator PDL1 is an Independent Prognostic Biomarker for Biochemical Recurrence in Prostate Cancer Patients Following Adjuvant Hormonal Therapy (2019 · Journal of Cancer · 被引 40)
• Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy (2021 · European Urology · 被引 37)
• Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial–Mesenchymal Transition (2021 · Frontiers in Molecular Biosciences · 被引 33)
• The Prognostic Value of External vs Internal Pancreatic Duct Stents in CR-POPF after Pancreaticoduodenectomy: A Systematic Review and Meta-analysis (2020 · Journal of Investigative Surgery · 被引 33)
• Analysis of the role of mutations in the KMT 2D histone lysine methyltransferase in bladder cancer (2019 · FEBS Open Bio · 被引 27)
• Preparation of a Photocured Biocompatible Hydrogel for Urethral Tissue Engineering (2021 · ACS Applied Polymer Materials · 被引 26)